Analyst Ratings for Corvus Pharmaceuticals (CRVS)
CRVS Rating Summary
CRVS Price Target Summary
- Highest: $42.00 (Jefferies)
- Lowest: $27.00 (H.C. Wainwright)
- Average: $31.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.80 (+101.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$31.80 (+101.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2025 | Barclays » Updated 1/21/2026 |
Etzer Darout | New Coverage | Overweight (N/A) |
28.00 (16.00) |
7.25 (15.80) |
117.93% | Details |
| 1/2/2025 | H.C. Wainwright » Updated 1/21/2026 |
Sean Lee | New Coverage | Buy (N/A) |
27.00 (11.00) |
5.35 (15.80) |
195.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
